Entity

Time filter

Source Type

Seongnam, South Korea

Patent
INtRON Biotechnology Inc. | Date: 2014-06-26

The present invention relates to a composition comprising EK99P-1, a bacteriophage isolated from nature and capable of infecting


The present invention relates to a magnetic resonance imaging (MRI) contrast agent, particularly a metal oxide nanoparticle-based T1-T2 dual-mode MRI contrast agent that can be used not only as a T1 MRI contrast agent but also as a T2 MRI contrast agent, and a method for producing the same. The metal oxide nanoparticle-based T1-T2 dual-mode MRI contrast agent can provide more accurate and detailed information associated with disease than single MRI contrast agent by the beneficial contrast effects in both T1 imaging with high tissue resolution and T2 imaging with high feasibility on detection of a lesion.


Patent
INtRON Biotechnology Inc. | Date: 2015-04-28

A composition includes an isolated bacteriophage Str-PAP-1 having the ability to kill


Vectors expressing kanA-kanB-kanK and other kanamycin production-related genes,


The present invention relates to a composition comprising the bacteriophage EK88P-1 isolated from the nature and having a broad antibacterial spectrum against

Discover hidden collaborations